These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 32387541)

  • 1. SARS-CoV-2 Testing, Prevalence, and Predictors of COVID-19 in Patients with Inflammatory Bowel Disease in Northern California.
    Gubatan J; Levitte S; Balabanis T; Patel A; Sharma A; Habtezion A
    Gastroenterology; 2020 Sep; 159(3):1141-1144.e2. PubMed ID: 32387541
    [No Abstract]   [Full Text] [Related]  

  • 2. Uneventful Course in Patients With Inflammatory Bowel Disease During the Severe Acute Respiratory Syndrome Coronavirus 2 Outbreak in Northern Italy.
    Norsa L; Indriolo A; Sansotta N; Cosimo P; Greco S; D'Antiga L
    Gastroenterology; 2020 Jul; 159(1):371-372. PubMed ID: 32247695
    [No Abstract]   [Full Text] [Related]  

  • 3. COVID-19 in Patients With Inflammatory Bowel Disease: A Single-center Observational Study in Northern Italy.
    Viganò C; Massironi S; Pirola L; Cristoferi L; Fichera M; Bravo M; Mauri M; Redaelli AE; Dinelli ME; Invernizzi P
    Inflamm Bowel Dis; 2020 Oct; 26(11):e138-e139. PubMed ID: 32949238
    [No Abstract]   [Full Text] [Related]  

  • 4. Are we underestimating seroprevalence of SARS-CoV-2?
    Burgess S; Ponsford MJ; Gill D
    BMJ; 2020 Sep; 370():m3364. PubMed ID: 32883673
    [No Abstract]   [Full Text] [Related]  

  • 5. 2019 Novel Coronavirus-Important Information for Clinicians.
    Del Rio C; Malani PN
    JAMA; 2020 Mar; 323(11):1039-1040. PubMed ID: 32022836
    [No Abstract]   [Full Text] [Related]  

  • 6. Special Issue on Diagnostic Testing for Severe Acute Respiratory Syndrome Coronavirus 2 and Lessons from This Pandemic.
    McAdam AJ
    J Clin Microbiol; 2020 Jul; 58(8):. PubMed ID: 32703896
    [No Abstract]   [Full Text] [Related]  

  • 7. [COVID-19 and Pulmonology: New Challenges and Opportunities].
    Clérigo V; Duarte P
    Acta Med Port; 2020 Oct; 33(10):710. PubMed ID: 32877327
    [No Abstract]   [Full Text] [Related]  

  • 8. Epidemiology and the Impact of Therapies on the Outcome of COVID-19 in Patients With Inflammatory Bowel Disease.
    Papa A; Gasbarrini A; Tursi A
    Am J Gastroenterol; 2020 Oct; 115(10):1722-1724. PubMed ID: 32826572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coronavirus and Patients With Inflammatory Bowel Disease: Management Strategies for the Practicing Clinician.
    Lichtenstein GR; Rubin DT
    Am J Gastroenterol; 2020 Oct; 115(10):1566-1569. PubMed ID: 32833732
    [No Abstract]   [Full Text] [Related]  

  • 10. Late Diagnosis of COVID-19 in Patients Admitted to the Hospital.
    Pfoh ER; Hariri EH; Misra-Hebert AD; Deshpande A; Jehi L; Rothberg MB
    J Gen Intern Med; 2020 Sep; 35(9):2829-2831. PubMed ID: 32542501
    [No Abstract]   [Full Text] [Related]  

  • 11. Rising numbers of positive covid-19 tests in the UK.
    Burgess S; Gill D
    BMJ; 2020 Sep; 370():m3605. PubMed ID: 32943434
    [No Abstract]   [Full Text] [Related]  

  • 12. SARS-CoV-2 diagnostic testing in Africa: needs and challenges.
    Adebisi YA; Oke GI; Ademola PS; Chinemelum IG; Ogunkola IO; Lucero-Prisno Iii DE
    Pan Afr Med J; 2020; 35(Suppl 2):4. PubMed ID: 32528615
    [No Abstract]   [Full Text] [Related]  

  • 13. COVID-19: Diagnostic Testing and Challenges.
    Ogbebor O; Min Z; Cheema T; Bhanot N
    Crit Care Nurs Q; 2020; 43(4):343-348. PubMed ID: 32833771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics of Hospitalized Adults With COVID-19 in an Integrated Health Care System in California.
    Myers LC; Parodi SM; Escobar GJ; Liu VX
    JAMA; 2020 Jun; 323(21):2195-2198. PubMed ID: 32329797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening Testing for SARS-CoV-2 upon Admission to Rehabilitation Hospitals in a High COVID-19 Prevalence Community.
    Kirshblum SC; DeLauter G; Lopreiato MC; Pomeranz B; Dawson A; Hammerman S; Gans BM
    PM R; 2020 Oct; 12(10):1009-1014. PubMed ID: 32700434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COVID-19 and inflammatory bowel disease: questions arising from patient care and follow-up during the initial phase of the pandemic (February-April 2020).
    Marín-Jiménez I; Zabana Y; Rodríguez-Lago I; Marín L; Barreiro-de Acosta M; Esteve M;
    Gastroenterol Hepatol; 2020; 43(7):408-413. PubMed ID: 32419715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SARS-CoV-2 (COVID-19) serology: implications for clinical practice, laboratory medicine and public health.
    Van Caeseele P; ; Bailey D; ; Forgie SE; ; Dingle TC; ; Krajden M;
    CMAJ; 2020 Aug; 192(34):E973-E979. PubMed ID: 32753391
    [No Abstract]   [Full Text] [Related]  

  • 18. Association of Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Testing Positive for Coronavirus Disease 2019 (COVID-19).
    Mehta N; Kalra A; Nowacki AS; Anjewierden S; Han Z; Bhat P; Carmona-Rubio AE; Jacob M; Procop GW; Harrington S; Milinovich A; Svensson LG; Jehi L; Young JB; Chung MK
    JAMA Cardiol; 2020 Sep; 5(9):1020-1026. PubMed ID: 32936273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patterns of IgG and IgM antibody response in COVID-19 patients.
    Liu X; Wang J; Xu X; Liao G; Chen Y; Hu CH
    Emerg Microbes Infect; 2020 Dec; 9(1):1269-1274. PubMed ID: 32515684
    [No Abstract]   [Full Text] [Related]  

  • 20. Low prevalence of active COVID-19 in Slovenia: a nationwide population study of a probability-based sample.
    Maver Vodičar P; Oštrbenk Valenčak A; Zupan B; Avšič Županc T; Kurdija S; Korva M; Petrovec M; Demšar J; Knap N; Štrumbelj E; Vehovar V; Poljak M
    Clin Microbiol Infect; 2020 Nov; 26(11):1514-1519. PubMed ID: 32688068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.